3Srinivas KC,Chantal B,Suzanne DJ,et al.Clinical audit in gynecological cancer surgery:Development of a risk scoring system to predict adverse events[J].Gynecol Oncol,2010,65(2):93-94.
4Gerestein CG,Damhuis RAM,de Vries M,et al.Causes of post-operative mortality after surgery for ovarian cancer[J].Eur J Cancer,2009,45(16):2799-2803.
5Gerestein CG,Damhuis RAM,Burger CW,et al.Postoperative mortality after primary cytoreduetive surgery for advanced stage epithelial ovarian cancer:A systematic review[J].Gynecol Oncol,2009,114(3):523-527.
6Janssen-Heijnen ML,Houterman S,Lemmensv E.et al.Prognostic impact of increasing age and CO-morbidity in cancer patients:a population-based approach[J].Crit Rev Oncol Hematol,2008,55(3):231-240.
7Lee GW,Pat WW,Sheryl GG,et al.Surgical complications asso-ciated with sentinel lymph node biopsy:Results from a prospective international cooperative group trial[J].Annal Surg Oncol,2009,13(4):491-500.
8Fimognari FL,Repetto L,More L,et al.Age,cancer and the risk of venous thromboembolism[J].Crit Rev Oncol Hematol,2005,55(3):207-212.
9Angiolo G,Stefania C,Nicoletta S,et al.The perioperative management of patients with gynaecological cancer undergoing major surgery:A debated clinical challenge[J].Crit Rev Oncol He-matol,2010,73(2):126-140.
